Tuesday, 5. November 2002
Topic: - on November 5, 2002 at 11:38:41 PM CET
Cannabis drugs pass testing 'milestone'
Cannabis-based drugs could be prescribed in the UK as early as 2003, following successful final-stage trials in patients with multiple sclerosis. Compared with standard treatments alone, the drugs significantly improved symptoms of MS and reduced pain caused by other types of nerve damage, GW Pharmaceuticals has announced. The company is the sole UK holder of a licence to cultivate and supply cannabis for medical research.
... Comment
